Navigation Links
Spark Therapeutics to Present at 32nd Annual J.P. Morgan Healthcare Conference
Date:12/20/2013

PHILADELPHIA, Dec. 20, 2013 /PRNewswire/ -- Spark Therapeutics, a fully integrated, late-stage gene therapy company, announced today that President and Chief Executive Officer Jeffrey D. Marrazzo will present a company overview at the 32nd Annual J.P. Morgan Healthcare Conference. Marrazzo's presentation will highlight the company's progress in developing potentially curative, one-time gene therapies for the treatment of inherited blindness and hemophilia, and provide an overview of Spark's expertise and capabilities in the clinical development of adeno-associated virus (AAV) vectors.  The presentation will take place at 1:30 PM PT on Tuesday, January 14, 2014 in the Elizabethan C room at the Westin St. Francis in San Francisco, California.

About Spark Therapeutics                                                                                           

Spark Therapeutics is developing potentially curative, one-time gene therapy products to transform the lives of patients and re-imagine the treatment of debilitating diseases. The founding team includes scientists who led the movement to develop gene therapy as a new treatment paradigm, establishing clinical proof of concept in the eye and liver and contributing key insights to the field that have resulted in a resurgence of industry interest in gene-based medicines. Our robust pipeline includes a Phase 3 program in RPE65 blindness and a Phase 1/2 program
'/>"/>

SOURCE Spark Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Snoring Therapy Awarded The Prestigious Spark Award
2. Kalyspo Awarded Best of Ann Arbor SPARK Boot Camp
3. Next Generation Sequencing Bioinformatics Heats up: Nearing $1000 Genome Sparks Soaring Data Output
4. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
5. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
6. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
9. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces ... Ltd., has received Chinese FDA (CFDA) approval and ... Tablets into the China ... and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., ... US FDA approved and China CFDA certified oral ...
(Date:8/20/2014)... 20, 2014   Easy Breathe , the fastest growing online ... Easy Blog " - has received more than 4.5 million unique ... "We are thrilled that so many people are finding our blog ... Easy Breathe. "We,re committed to making sleep apnea more widely known ... informed about sleep apnea news , troubleshooting advice , ...
(Date:8/20/2014)... , August 20, 2014 ... subsidiary of Glenmark Pharmaceuticals Limited India (GPL), announces ... of a novel clinical development candidate, GBR 1302, ... and developed by the Glenmark Biologics Research Centre ... . GBR 1302 is based on Glenmark,s innovative ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3
... SAN DIEGO, May 16, 2011 Cardium Therapeutics ... its financial results for the first quarter ended ... ) (Logo:   http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO ) ... quarter 2011 financial results, Cardium reported on the ...
... R.I., May 16, 2011 Obtaining prior authorization for ... and pharmacists that currently requires phone calls, faxes and ... they do not provide both a real-time solution and ... health record (EHR) tools.  Recognizing this gap in the ...
Cached Medicine Technology:Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 2Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 3Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 4Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 5Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 6Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 7Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 8Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 9Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 10CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication 2CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication 3
(Date:8/20/2014)... Verndale is pleased to announce their recent ... list ranking the fastest-growing private companies in America. The ... yearly percentage revenue growth over a three-year period. For ... 5000 list where it ranked number 2,855. , As ... a wide range of digital marketing services including core ...
(Date:8/20/2014)... North Carolina (PRWEB) August 20, 2014 ... , findings from a University College London (UCL) study ... disagreed on what method of brushing teeth was the ... found that six different tooth-brushing techniques were frequently recommended, ... the Charlotte Center for Cosmetic Dentistry, experienced cosmetic ...
(Date:8/20/2014)... 20, 2014 Oxnard dentist ... the Anacapa Dental Art Institute, is presenting at the ... will be speaking on All-on-4 dental implants ... Graft Less Solutions” at 12:40 p.m. Sept. 20 at ... British Columbia, Canada. , “The All-on-4 procedure gives patients ...
(Date:8/20/2014)... 20, 2014 Biosimilars, which are ... approved through an abbreviated process, could reap billions ... Atlantic Information Services, Inc.’s (AIS) Specialty Pharmacy News ... including the Food and Drug Administration’s (FDA) recent ... towards approval. , Drugmaker Sandoz said July 24 ...
(Date:8/20/2014)... 20, 2014 No matter how “lonely” a ... a steady set of friends to be always there for ... to the concept of making new friends during adulthood ... ranging from taking care of one’s family to a near-slavish ... to a new person just is not the same as ...
Breaking Medicine News(10 mins):Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 2Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 3Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 2Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 3Health News:‘How to Make Friends as an Adult by Just Being Yourself: Becoming a “People Person” In Three Steps or Less’ Gives Tips for Making Friends During Adulthood - Vinamy 2
... the psychiatrist Dr Charles Reynolds at the University of Pittsburgh ... , The study’s main aim was to analyze ... elderly people. It is one of the longest studies ... prescribe antidepressants for longer periods, perhaps even for life, in ...
... Department of New South Wales has conducted a study which ... the user's physical health// . , It is ... Cannabis abuse can lead to cardiovascular, respiratory and immune system ... slow brain development at a young age. New South Wales ...
... Yale shed new light on the mechanism of nerve ... "motor" protein, myosin-II, according to an //article in the ... develop or attempt to recover after damage, they extend ... sensors. Growth cones use the information they gather to ...
... shorts in football prints and innerwear with net inserts ... lingerie designers are experimenting with.,Overall, the trend in lingerie ... with a hint of romance. The seductive undergarments require ... being tried with embroidery. The garments aren't so opulent, ...
... overcrowding of farm owners in local veterinary centres has created much ... Nadub //. The deadly avian influenza virus outbreak in India was ... 20 chickens dropped dead Saturday in Manakkad area of Salem district, ... for tests. ,Tamil Nadu has been on high alert ...
... pain by taking Oxycontin, a prescription painkiller. Later on for ... cheaper option. // Michaud, now 18 years is one ... prescription drugs. Teenagers are increasingly experimenting with legal drugs like ... from medicine cabinets. , Health officials say that ...
Cached Medicine News:Health News:Drugs Are Effective In Treating Depression and Preventing Recurrence 2Health News:A New Focus For The Mechanism Of Nerve Growth 2Health News:Romantic and discreet trends in lingerie 2Health News:New Generation Teenagers Addiction to Prescription Drugs 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: